Portal TFL
Judgment of the Court (Third Chamber) of 19 December 2024.#Teva BV and Teva Finland Oy v Merck Sharp & Dohme LLC and Merck Sharp & Dohme LLC v Clonmel Healthcare Limited.#Reference for a preliminary ruling – Medicinal products for human use – Supplementary protection certificate (SPC) – Regulation (EC) No 469/2009 – Conditions for obtaining an SPC for medicinal products – Article 3(a) – Concept of ‘product protected by a basic patent in force’ – Article 3(c) – Concept of ‘product the subject of an SPC’ – Criteria for assessment.#Joined Cases C-119/22 and C-149/22.
GENERALNI PRAVOBRANILEC
CASE LAW DIRECTORY CODE
NUMPUB
OPRAVILNA ŠTEVILKA (*)
C-119/22 and C-149/22
SODNIK POROČEVALEC
OPAZOVALCI
STRANKE (*)
Teva BV and Teva Finland Oy v Merck Sharp & Dohme LLC and Merck Sharp & Dohme LLC v Clonmel Healthcare Limited
CELEX ŠTEVILKA (*)
62022CJ0119_SUM
SUBJECT_PODROČJE
TIP PROCEDURE (*)
POVZETEK
Za ogled celotnega dokumenta je potrebna prijava v portal.
Začnite z najboljšim.
VSE NA ENEM MESTU.